| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |